Ketotifen is indicated for long-term prevention of all forms of the bronchial asthma, allergic bronchitis and asthma manifestations in allergic rhinitis and also for the prevention and treatment of allergic diseases, including - acute and chronic urticaria, atopic dermatitis and allergic rhinitis.
Dosage & Administration
Ketotifen should be taken orally with meal. Adult: 1 mg, 2 times daily, in the morning and in the evening. In case of insufficient effect after 4-week treatments, the dose could be increased up to 2 mg, 2 times daily. Children (6 months - 3 years): 0.5 mg (2.5 ml syrup), 2 times daily. Children (older than 3 years): 1 mg, 2 times daily (in the
morning and in the evening). The treatment with Ketotifen should be discontinued gradually, with gradual reduction of the dose within 2-4 weeks, in order to avoid the risk of asthma symptoms recidivating. It is advisable the treatment to continue 2-3 months.
In patients sensitive to the sedative effect of the preparation, initial dose should be half of the usual, which could be gradually increased. In order to avoid suprarenal insufficiency, in patients treated regularly with corticosteroids, Ketotifen should be started after gradually reducing the corticosteroid dose, or elongation of the interdosage intervals. In case of intercurrent infections, Ketotifen should not be discontinued. At the beginning of the treatment, Ketotifen may cause patient reaction disorders, which requires enhanced attention in drivers and machinery operating persons. In pregnancy: Ketotifen has been categorized as pregnancy category C. In lactating mother: Caution should be exercised when Ketotifen Fumarate is administered to a nursing mother.